15 challenges at the intersection of biology & AI

A new Perspective in Cell, co-authored by HIP Co-Chief Science Officer John Tsang alongside leading researchers from Columbia, Stanford, and the Chan Zuckerberg Initiative, tackles one of the biggest open questions in biomedical AI: why hasn’t generative AI’s success in protein folding translated to predicting how cells and tissues actually behave? Drawing inspiration from Hilbert’s landmark list of 23 mathematical problems, the authors propose fifteen concrete challenges to focus the field — spanning molecular interactions, cell-state reprogramming, drug response, and clinical trial prediction — each paired with rigorous benchmarks for measuring real progress.

Spoiler alert: HIP is called out as a model for what comes next.

Fifteen challenges for generative AI applications to cell biology

Recent Posts

  • How do you measure an aging immune system? HIP Co-CSOs publish new framework.

    A new Nature Medicine Perspective, “Immune Aging Biomarkers for Clinical Trials,” tackles a question at the heart of HIP’s mission: there’s still no agreed-upon way to measure immune aging. Co-authored by HIP Co-Chief Scientific Officers Shai Shen-Orr and John Tsang, alongside researchers from Stanford, Yale, UConn, University College London, the National Institute on Aging, and others, the... Read More
  • HIP Impact Session – Davos 2026

    Open-science initiative makes the case for mapping the human immunome as the next frontier in medicine DAVOS, SWITZERLAND – January 21, 2026 — The Human Immunome Project (HIP) was invited to host a dedicated Impact Session at Frontiers Science House, the World Economic Forum’s science-focused venue on the Davos promenade, during its 56th Annual Meeting, January... Read More

Responses

Respond

Your email address will not be published. Required fields are marked *